Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
This document corrects two outdated references that should have been deleted and one outdated reference in the final rule that appeared in the February 2, 2024 Federal Register titled "Medications for the Treatment of Opioid Use Disorder," specifying final modified and updated certain provisions related to Opioid Treatment Program (OTP) accreditation, certification, and standards for the treatment of Opioid Use Disorder with Medications for Opioid Use Disorders in OTPs. The effective date of the final rule was April 2, 2024, and the compliance date was October 2, 2024.
Published
Feb 23, 2026
Effective
Feb 23, 2026
Citation
91 FR 8381
Agencies
1
Full text not available in our database.
View on Federal Register →Get a plain-English explanation of what this regulation does, which agencies are responsible, and how it affects existing rules.
No document text available yet
0930-AA39
42 CFR 8